Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
NeoGenomics, Inc. - Common Stock
(NQ:
NEO
)
12.08
+0.32 (+2.72%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about NeoGenomics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Demystifying NeoGenomics: Insights From 6 Analyst Reviews
↗
February 19, 2025
Via
Benzinga
Why NeoGenomics (NEO) Shares Are Trading Lower Today
February 18, 2025
Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) fell 21.5% in the afternoon session after the company reported weak fourth-quarter results, with revenue falling below Wall...
Via
StockStory
NeoGenomics (NASDAQ:NEO) Misses Q4 Sales Targets
February 18, 2025
Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 10.6% year on year to $172 million. On the other hand, the...
Via
StockStory
NeoGenomics Reports Fourth Quarter and Full Year 2024 Results
February 18, 2025
From
NeoGenomics, Inc.
Via
Business Wire
5 Analysts Assess NeoGenomics: What You Need To Know
↗
January 15, 2025
Via
Benzinga
Evaluating NeoGenomics: Insights From 4 Financial Analysts
↗
December 10, 2024
Via
Benzinga
Expert Ratings For NeoGenomics
↗
September 24, 2024
Via
Benzinga
Earnings Scheduled For February 18, 2025
↗
February 18, 2025
Via
Benzinga
NeoGenomics (NEO) To Report Earnings Tomorrow: Here Is What To Expect
February 17, 2025
Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) will be reporting results tomorrow morning. Here’s what to look for.
Via
StockStory
NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025
January 29, 2025
From
NeoGenomics, Inc.
Via
Business Wire
Stock Market Rises On Tame Inflation, Bank Earnings: Weekly Review
↗
January 17, 2025
Many stocks flashed buy signals as the major indexes rose to or above key levels.
Via
Investor's Business Daily
Topics
Economy
NeoGenomics Is On The Upswing, Reversing A CEO-Tied Sell-Off, On Bullish Long-Term Guidance
↗
January 15, 2025
The company expects sales to grow 12% to 13% annually in the long term.
Via
Investor's Business Daily
NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan
January 15, 2025
From
NeoGenomics, Inc.
Via
Business Wire
Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients
January 14, 2025
Pairing Adaptive Biotechnologies’ clonoSEQ MRD results with NeoGenomics’ COMPASS and CHART assessment services empowers clinicians and patients with meaningful insights across the treatment continuum
From
Adaptive Biotechnologies
Via
GlobeNewswire
NeoGenomics Shares Are Falling Today: What's Going On?
↗
January 10, 2025
Shares of NeoGenomics, Inc. (NASDAQ: NEO) are, after the company announced that CEO Chris Smith will retire effective April 1 2025.
Via
Benzinga
NeoGenomics Announces Chief Executive Officer Succession
January 10, 2025
From
NeoGenomics, Inc.
Via
Business Wire
NeoGenomics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
January 06, 2025
From
NeoGenomics, Inc.
Via
Business Wire
NeoGenomics’ Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma
December 11, 2024
From
NeoGenomics, Inc.
Via
Business Wire
NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting
December 09, 2024
From
NeoGenomics, Inc.
Via
Business Wire
NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment
November 19, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Felicia Williams Joins NeoGenomics Board of Directors
November 14, 2024
From
NeoGenomics, Inc.
Via
Business Wire
NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference
November 08, 2024
From
NeoGenomics, Inc.
Via
Business Wire
NeoGenomics Reports Third Quarter 2024 Results
November 05, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Earnings Scheduled For November 14, 2024
↗
November 14, 2024
Via
Benzinga
NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test
October 22, 2024
From
NeoGenomics, Inc.
Via
Business Wire
NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024
October 15, 2024
From
NeoGenomics, Inc.
Via
Business Wire
NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia
October 08, 2024
From
NeoGenomics, Inc.
Via
Business Wire
NeoGenomics Announces New RaDaR Technology and Resolution of RaDaR 1.0 Litigation
September 23, 2024
From
NeoGenomics, Inc.
Via
Business Wire
NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment
September 11, 2024
From
NeoGenomics, Inc.
Via
Business Wire
NeoGenomics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
August 29, 2024
From
NeoGenomics, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
